Roth Capital Starts ImmunoCellular Therapeutics (IMUC) at Buy
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Price: $0.27 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 1
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 1
Join SI Premium – FREE
Earlier, Roth Capital initiated coverage on ImmunoCellular Therapeutics (NYSE: IMUC) with a Buy. PT $6.00.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.03 yesterday.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Banco de Sabadell SA (SAB:SM) (BNDSF) at Underweight
- Berenberg Starts Alm Brand A/S (ALMB:DC) at Hold
- Truist Securities Starts Nuscale Power (SMR) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
